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ICSBP Directs Bipotential Myeloid Progenitor
Cells to Differentiate into Mature Macrophages
(ICSBP), also designated interferon regulatory factor 8
(IRF-8), is a transcription factor of the IRF family (Nguyen
et al., 1997). This family includes more than eight mem-
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bers, all of which have the conserved DNA binding do-National Institute of Child Health
main (DBD) that recognizes the consensus sequence,and Human Development
AANNGAAA (Fujii et al., 1999). This element, containedNational Institutes of Health
in the interferon-stimulated response element (ISRE), isBethesda, Maryland 20892
present in many interferon (IFN) a/b±inducible genes,
as well as other genes (Darnell et al., 1994). ICSBP is
expressed exclusively in the hematopoietic cells, includ-
Summary ing cells of the monocyte/macrophage lineage, B lym-
phocytes, and activated T lymphocytes, and is inducible
During hematopoiesis, myeloid progenitor cells give by IFNg in these cells (Nelson et al., 1996; Kantakamala-
rise to granulocytes and macrophages. To study the kul et al., 1999). Several lines of studies indicate that
role for ICSBP, a hematopoietic cell-specific transcrip- ICSBP acts by associating with other transcription fac-
tors. For example, ICSBP interacts with IRF-1 and IRF-2tion factor in myeloid cell development, the gene was
to bind to the ISRE and negatively regulates some IFN-introduced into myeloid progenitor cells established
inducible genes (Sharf et al., 1995). It also associatesfrom ICSBP2/2 mice. ICSBP retrovirus-transduced
with PU.1 and stimulates activity of promoters carryingcells differentiated into mature macrophages with
an Ets-IRF composite element (EICE) (Brass et al., 1999;phagocytic activity, which coincided with the induc-
Marecki et al., 1999; Meraro et al., 1999). PU.1 alsotion of specific target DNA binding activity. Similar to
interacts with another IRF member, IRF-4 (Pip), to acti-macrophages in vivo, ICSBP-transduced cells were
vate transcription through the EICE (Eisenbeis et al.,growth arrested, expressed many macrophage-spe-
1995).cific genes, and responded to macrophage activation A series of studies performed with ICSBP2/2 mice
signals. Contrary to this, ICSBP transducion led to (Holtschke et al., 1996) indicates that ICSBP has a criti-
repression of granulocyte-specific genes and inhibited cal role in the development of myeloid cells. First,
G-CSF-mediated granulocytic differentiation in these ICSBP2/2 mice develop a chronic myelogenous leukemia
and other myeloid progenitor cells. Together, ICSBP (CML)±like syndrome. Second, while the number of gran-
has a key role in the myeloid cell lineage selection and ulocytes is strikingly increased in these mice, cells bear-
macrophage maturation. ing macrophage markers in ICSBP2/2 bone marrow are
significantly reduced. Further, the macrophage colony±
forming ability in ICSBP2/2 bone marrow is impairedIntroduction
(Scheller et al., 1999). In addition, ICSBP2/2 macro-
phages appear to have some immature traits and arePluripotent hematopoietic stem cells undergo progres-
functionally defective. They do not respond well to thesive restriction in their lineage potential to give rise to
macrophage activating signals, causing ICSBP2/2 micemature, terminally differentiated cells. The process of
highly susceptible to infections (Fehr et al., 1997; Schar-hematopoietic differentiation is thought to follow a de-
ton et al., 1997). ICSBP2/2 myeloid cells are also shownvelopmentally ordered pattern of gene expression. Re-
to be defective in apoposis (Gabriele et al., 1999). Recentcent studies reveal that transcription factors play a major
evidence indicates that ICSBP plays a significant rolerole in the lineage determination and maturation of he-
in myeloid cell malignancies; ICSBP expression is re-matopoietic cells (Shivdasani and Orkin, 1996; Tenen et
ported to be reduced in CML patients (Schmidt et al.,al., 1997). Some of hematopoietic disorders and leuke-
1998) and in the murine model of a CML-like diseasemias are attributed to the dysregulation of the activities
induced by Bcr-Abl. Supporting the involvement ofof specific transcription factors (Tenen et al., 1997).
ICSBP in CML, the murine disease is reported to beIn the myeloid lineage, both granulocytes and macro-
ameliorated by coexpression of ICSBP (Hao and Ren,phages are derived from common progenitor cells (Met-
2000). These observations raise the possibility thatcalf, 1989). There are transcription factors shown to be
ICSBP has a role in regulating pathways affecting lin-important for myeloid cell development including PU.1
eage commitment and myeloid cell differentiation.of the Ets family, which affects multiple lineages of he-
By retroviral transduction, we have introduced ICSBPmatopoiesis in an early stage (Lloberas et al., 1999).
into myeloid progenitor cells established from ICSBP2/2C/EBPa and e, belonging to the bZip family, are involved
bone marrow. We show that cells transduced with
in granulocyte maturation (Yamanaka et al., 1997; Ra- ICSBP differentiate into functional macrophages and
domska et al., 1998). Egr-1, a zinc finger factor is shown express many macrophage-specific genes. In contrast,
to be capable of driving macrophage differentiation in ICSBP transduction strongly inhibited granulocytic dif-
some cells (Nguyen et al., 1993). There are additional ferentiation in these and other myeloid progenitor cells.
transcription factors reported to have a role in differenti- This inhibition coincided with the repression of genes
ation of myeloid cells (Nagamura-Inoue et al., 2000). involved in granulocytic differentiation. These results
Interferon consensus sequence binding protein demonstrate that ICSBP has a fundamental role in the
lineage selection as well as the maturation and activa-
tion of macrophages. Finally, DNA binding activities for* To whom correspondence should be addressed (e-mail: ozatok@
mail.nih.gov). the ISRE and EICE examined both in vivo and in vitro
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Figure 1. Establishment of ICSBP2/2 Myeloid Progenitor Cell Line Tot2
(A) Wright-Giemsa stain of Tot2 cells (3 600).
(B) Flow cytometric analysis. Tot2 cells were stained with the indicated antibodies. Thin lines, profiles in the absence of specific antibody;
bold lines, profiles in the presence of specific antibody.
(C) Wright-Giemsa stain of Tot2 cells treated with G-CSF (10 ng/ml) for 4 days (3 600).
indicate that ICSBP regulates myeloid cell development with either the ICSBP-MSCV retrovirus or the control
MSCV without insert and selected with puromycin start-through its transcriptional activity.
ing 2 days after virus transduction. As shown in Figure
2A, ICSBP-transduced Tot2 cells differentiated into cellsResults
with macrophage-like morphology. During the 6 day in-
cubation period, the cytoplasmic area progressively in-Establishment of ICSBP2/2 Myeloid Progenitor
creased and became less basophilic, filled with vacu-Cell Lines
oles. The nucleus that initially occupied a large area ofICSBP2/2 mice exhibit a syndrome similar to CML. We
the cell became smaller and presented a condensedhave established several cell lines from bone marrow
appearance by day 6. Furthermore, unlike the originalof ICSBP2/2 mice undergoing blast crisis, the fatal stage
Tot2 cells, many ICSBP-transduced cells firmly adheredof the disease. One representative line, Tot2 displayed
to the plastic plate, a feature noted for macrophages.a morphology of immature blasts and grew in a granulo-
Along with these changes, immature blast cells werecyte/macrophage colony±stimulating factor (GM-CSF)±
gradually diminished in frequency and became a smalldependent manner. Wright-Giemsa staining shown in
minority on day 6. In contrast to the striking changesFigure 1A revealed that Tot2 cells possessed a high
observed by the cells with the ICSBP virus, cells trans-nuclear:cytoplasmic ratio with a basophilic cytoplasm
duced with the control virus showed no change in ap-containing a few azurophilic granules. Flow cytometric
pearance and remained nonadherent during this periodanalysis in Figure 1B showed that Mac-1 (CD11b) and
(Figure 2A). The time course of morphological changesGr-1 (Ly-6G), markers for myeloid cells were both ex-
observed after virus transduction is depicted in Figurepressed in Tot2 cells at moderate levels. B220 (CD45R)
2B. In an early stage on day 3, just after the beginning ofand Thy1.2 (CD90.2), markers for the B and T lymphocyte
puromycin selection, about 40% of ICSBP-transducedlineages, respectively, were not detected in these cells.
cells retained large nuclei showing an intermediate mor-We found that when Tot2 cells were transferred into
phology. On day 4, about 25% of cells displayed moremedia containing granulocyte colony±stimulating factor
advanced macrophage-like morphology. In the later(G-CSF) without GM-CSF, the majority of the cells differ-
stage, on day 6, z80% of cells manifested an appear-entiated into granulocytes within several days (Figure
ance of fully mature macrophages.1C). Following 4 days of G-CSF treatment, z70% of
cells became morphologically distinct granulocytes with
characteristic band/segmented nuclei. Another cell line Induction of ISRE and EICE Binding Activities
established in the same manner but from a different in ICSBP-Transduced Cells
mouse also expressed Mac-1 and Gr-1, grew in the ICSBP regulates transcription of a wide range of target
presence of GM-CSF, and, similar to Tot2, underwent genes that carry a cis regulatory element ISRE or EICE
granulocytic differentiation when cultured in the pres- in the promoter. ICSBP binds tightly to the ISRE when
ence of G-CSF (data not shown). Thus, these bone mar- it interacts with other IRF proteins, such as IRF-1 and
row±derived cell lines have a potential for granulocytic IRF-2 (Sharf et al., 1995). It also binds to the composite
differentiation, a feature of myeloid progenitor cells. element, EICE by interacting with PU.1 (Brass et al.,
1999; Marecki et al., 1999; Meraro et al., 1999). To assess
whether ICSBP transduction changes factor binding ac-Macrophage Differentiation Induced by Retrovirus
Transduction of ICSBP tivity for these elements, electrophoretic mobility shift
assays (EMSA) were performed using 32P-labeled ISREIn order to study a role for ICSBP in myeloid cell growth
and maturation, we transduced a retrovirus harboring and EICE probes. Figure 2C shows results obtained with
nuclear extracts from cells transduced with the ICSBPICSBP into Tot2 cells. The retrovirus vector used here
was based on the murine stem cell virus (MSCV) and virus for 3 days. While ISRE binding activity was
absent in cells transduced with the control virus, cellscontained the puromycin resistant gene used for selec-
tion (Hawley et al., 1994). Tot2 cells were transduced transduced with ICSBP virus produced three distinct
Regulation of Myeloid Differentiation by ICSBP
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Figure 2. Macrophage Differentiation of Tot2 Cells Induced by ICSBP
(A) Wright-Giemsa stain of Tot2 cells transduced with the control virus or ICSBP virus for indicated days.
(B) Time course of the appearance of macrophages after ICSBP virus transduction. Cells at each time point were classified into three types
according to the status of morphological differentiation. See (A) for typical examples for immature (a), intermediate (b and d), and mature cell
types (f). Values were obtained from counts of .250 cells.
(C) EMSA detection of DNA binding activity in ICSBP virus±transduced cells. Nuclear extracts from Tot2 cells 3 days post virus transduction
were analyzed with radiolabeled ISRE or EICE probe. In lanes 3±6, extracts from ICSBP-transduced cells were preincubated with anti-ICSBP
antibody, normal rabbit IgG, or 100-fold excess unlabeled probe prior to addition of labeled probe. The binding activities containing ICSBP
protein are indicated as ICSBP complex.
(D) Immunoblot detection of ICSBP expression. Nuclear extracts (30 mg) from Tot2 cells 6 days post transduction or the macrophage line
Raw264.7 cells were analyzed by immunoblot using anti-ICSBP antibody.
ISRE binding activities. The uppermost band contained with the preexisting PU.1, presumably represented by
the intense lower band (see Figure 6). All three bandsICSBP, since it was largely eliminated by antibody to
ICSBP and was likely to be ICSBP-IRF complexes de- were eliminated by the specific competitor.
These results demonstrate that the functional ICSBPscribed previously (Sharf et al., 1995). ICSBP virus-trans-
duced cells produced two additional bands, an upper protein was expressed in Tot2 cells upon ICSBP virus
transduction and that they generate additional DNAweak band and intense lower band (asterisk in Figure
2C). All three bands were specific for ISRE since they binding activities specific for ISRE and EICE. The induc-
tion of target DNA binding activity may promote induc-were removed by specific competitor oligomers. Since
the lower two bands were not eliminated by ICSBP anti- tion of different transcriptional activities in Tot2 cells.
In agreement with these results, expression of ICSBPbody, these may represent binding of another IRF mem-
ber regulated by ICSBP (Holtschke et al., 1996). The protein and the mRNA was confirmed in ICSBP-trans-
duced cells by immunoblot analysis (Figure 2D), RT-EICE probe yielded two shifted bands, namely a weak
upper band and intense lower band in control cells. PCR (Figure 4B), and RNA blot analysis (Figure 6E). The
levels of ICSBP protein expressed in Tot2 cells wereWhereas, ICSBP-transduced cells showed an addi-
tional, more slowly migrating band, not present in con- moderate and relatively constant throughout the 6 day
culture period and roughly comparable with those oftrol cells, which was eliminated by anti-ICSBP antibody.
This band is likely to be an ICSBP/PU.1 complex formed a macrophage cell line Raw264.7 cells, indicating that
Immunity
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after ICSBP transduction, while it remained expressed
in control cells. These results substantiate the morpho-
logical observations above and verify that ICSBP trans-
duction leads to macrophage differentiation in Tot2
cells.
Semiquantitative reverse transcriptase±polymerase
chain reaction (RT-PCR) was carried out to test ex-
pression of genes linked to myeloid cell differentiation
(Figure 4B). Expression of the macrophage colony±
stimulating factor receptor (M-CSFR) gene, c-fms,
known to stimulate growth and differentiation of mono-
cytes and macrophages (Hume et al., 1997) was signifi-
cantly increased as early as 2 days after ICSBP trans-
duction. In contrast, c-fms levels were very low in control
cells and remained unchanged throughout the 6 day
culture period. Additionally, the macrophage-specific
scavenger receptor (SR) gene (Moulton et al., 1994) was
dramatically induced 4 days after ICSBP transduction
and remained high for the rest of the period. SR tran-
scripts were undetectable in control cells throughout
Figure 3. Cell Growth Arrest in ICSBP-Transduced Cells this period. Furthermore, Egr-1, a transcription factor
(A) The growth rate of Tot2 cells transduced with the indicated reported to induce macrophage differentiation in several
viruses. Total cell yields are counted at indicated days. cultured cells (Nguyen et al., 1993) was strongly induced
(B) Cell cycle analysis. Cells transduced with control or ICSBP virus on day 4 in ICSBP-induced cells, with a slight decline
were analyzed for DNA contents at indicated days.
on day 6. In control cells, expression of Egr-1 transcripts
remained at the background level. On the other hand,
levels of the myeloperoxidase (MPO) gene, known to beICSBP was expressed at physiological levels upon
downregulated during myeloid differentiation (Lubberttransduction.
et al., 1991), were high in both ICSBP and control cells
up to day 4, but sharply fell in ICSBP-transduced cells
Cell Growth Arrest that Coincides on day 6. In contrast, MPO levels remained high in con-
with Macrophage Differentiation trol cells. These results show that ICSBP alters gene
The cell growth curve in Figure 3A showed that prolifera- expression patterns along the monocyte/macrophage
tion of Tot2 cells was drastically reduced following differentiation pathway.
ICSBP virus transduction, leading to almost complete Opposite to the induction of genes associated with
growth arrest by day 5. In contrast, cells transduced macrophage differentiation, genes linked to granulo-
with control virus continued to grow exponentially. Cell cytic differentiation were downregulated after ICSBP
cycle profiles obtained from virus-transduced cells on transduction. First, levels of G-CSF receptor (G-CSFR)
day 3 through day 6 showed that upon ICSBP transduc- were decreased after ICSBP transduction. However,
tion, the percentage of cells in S phase was progres- G-CSFR levels remained roughly constant in control cells.
sively decreased with an inverse increase in the percent- C/EBPa and e are transcription factors reported to have
age of cells in G1 phase (Figure 3B). On day 6, more a role in granulocytic differentiation (Yamanaka et al.,
than 87% of ICSBP-transduced cells were in G1. In con- 1997; Radomska et al., 1998). The levels of the C/EBPs,
trast, the percentage of cells in S and G1 remained especially C/EBPe transcripts, were significantly de-
essentially constant in control cells. These results indi- creased in ICSBP-transduced cells, while essentially un-
cate that ICSBP-induced differentiation is coupled with changed in control cells throughout 6 days of culture.
marked growth arrest at the G1 phase of cell cycle. On the other hand, expression of pan-myeloid genes
It should be stated here that another ICSBP2/2 progen- such as PU.1, GM-CSFRa, and GM-CSFbc did not
itor cell line also underwent differentiation after ICSBP change significantly during this period both in ICSBP-
virus transduction, exhibiting very similar morphological transduced cells and control cells. These results indi-
changes as those observed with Tot2 cells. These re- cate that upon ICSBP transduction, genes linked to
sults indicate that macrophage differentiation by ICSBP macrophage differentiation and function are induced in
is not an isolated example applicable only to Tot2 cells Tot2 cells in an ordered fashion, while genes linked to
(data not shown). granulocytic differentiation are repressed in a timely
fashion.
Expression of Macrophage-Specific Genes and In light of the induction of c-fms transcripts in ICSBP-
Surface Markers in ICSBP-Transduced Cells transduced cells (Figure 4B), it was of interest to test
To ascertain whether ICSBP-transduced cells expressed whether macrophage differentiation induced by ICSBP
cell surface markers specific for macrophages, flow cy- was attributed to a possible autocrine mechanism
tometric analysis was performed. As shown in Figure whereby a sole differentiation signal may come from the
4A, the majority of ICSBP-transduced cells expressed interaction of c-fms with M-CSF (Stanley, 1985). To test
F4/F80, a specific marker for macrophages (Morris et this possibility, cells were incubated with the varying
al., 1991), while this marker was not expressed in control concentrations of the neutralizing anti-M-CSF antibody
cells. Similarly, the Mac-1 levels were markedly in- from the beginning of virus transduction through the
creased in ICSBP-transduced cells, while unaffected end of 6 day culture. Macrophage differentiation was
in control cells. On the other hand, Gr-1, known to not at all affected by the inclusion of antibody (data not
shown), indicating that under these conditions ICSBPbe negative in macrophages, was largely undetectable
Regulation of Myeloid Differentiation by ICSBP
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Figure 4. Expression of Cell Surface Markers and Macrophage-Related Genes in ICSBP-Transduced Tot2 Cells
(A) Flow cytometric analysis. Indicated surface markers were analyzed for cells 6 days post transduction
(B) Semiquantitative RT-PCR analysis. Expression of indicated transcripts was analyzed using RNA from cells at indicated days.
induces macrophage differentiation without requiring a T cell±mediated immune responses (Trinchieri, 1998).
The iNos produces nitric oxide, one of critical antimi-significant amount of M-CSF. Consistent with these re-
sults, addition of M-CSF to the media or replacing GM- crobial agents produced in macrophages (MacMicking
et al., 1997). Whereas, FcgRI is involved in immuno-CSF with M-CSF did not cause macrophage differentia-
tion in parental Tot2 or control virus-transduced cells. globulin-mediated signaling important for enhanced
phagocytosis and tumor-killing activity (Amigorena and
Bonnerot, 1999). Results in Figure 5B showed that allFunctionality of ICSBP-Transduced Macrophages
three genes were markedly induced following IFNg andGiven the expression of macrophage-specific genes in
LPS treatment in ICSBP-transduced cells. While IL-12ICSBP-transduced cells, it was of interest to study their
p40 induction was observed only in ICSBP-transducedfunctionality. To this end, we first tested phagocytic
cells, iNos and FcgRI transcripts were induced bothactivity, the oldest known function of macrophages.
in ICSBP and control cells after IFNg/LPS treatment,Tot2 cells transduced with ICSBP virus were incubated
although their levels were more than 7-fold lower inwith fluorescent latex particles for 2 hr. As shown in
control cells than in ICSBP-transduced cells (Figure 5B).Figure 5A, ICSBP-transduced cells robustly took up la-
These results demonstrate that expression of ICSBPtex particles and became intensely fluorescent. In con-
alone enables progenitor cells to become mature macro-trast, cells transduced with the control virus did not
phages endowed with phagocytic activity and the abilitytake up latex particles at all, indicating that they had no
to respond to the macrophage activation signals.phagocytic activity.
We then investigated another criterion of macrophage
function, the responsiveness to IFNg and bacterial lipo- Domain Requirement for ICSBP-Induced
Macrophage Differentiationpolysaccharide (LPS) (Unanue, 1993). When macro-
phages reach a certain stage of maturation, they acquire ICSBP has the conserved DNA binding domain (DBD)
in the N-terminal region and the IRF association domainresponsiveness to IFNg and LPS, which potently acti-
vate macrophage. We tested induction of interleukin-12 (IAD) in the C-terminal region (Meraro et al., 1999). The
DBD contains the conserved lysine (K) at 79 that is re-(IL-12) p40, nitric oxide synthase (iNos), and Fcg recep-
tor I (FcgRI) transcripts by RT-PCR. IL-12 p40 encodes quired for DNA binding activity (Ortiz et al., 1999). The
IAD contains an a helix motif at amino acids 361±375the inducible subunit of the cytokine and is essential for
Immunity
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macrophages that were morphologically indistinguish-
able from those induced by the wild-type ICSBP. Fur-
thermore, they expressed the SR and c-fms transcripts
at high levels, as cells transduced with the wild-type
ICSBP (Figure 6F). However, the mutants that failed to
induce differentiation failed to induce the transcripts in
transduced cells. Cells transduced with these mutants
maintained the appearance of immature blasts and con-
tinued to proliferate rapidly without growth arrest. The
absence of macrophage differentiation by these mu-
tants was not due to an insufficient expression of mutant
ICSBPs, since mutant transcripts were expressed at
levels even higher than the wild-type ICSBP in these
cells (Figure 6E). These results show that macrophage
differentiation induced by ICSBP is dependent on its
ability to associate with other factors and to bind to
the target DNA elements, the primary requirement for
transcriptional activity.
Exogenous ICSBP Represses G-CSF-Mediated
Granulocytic Differentiation in Tot2
and 32Dcl.3 Cells
We observed that ICSBP virus±transduced Tot2 cells
did not differentiate into granulocytes even when the
culture media was supplemented with G-CSF starting
on day 1. Instead, they differentiated into macrophage-
like cells. However, under the same conditions, control
virus±transduced cells differentiated into granulocytes,
as in the parental Tot2 cells (data not shown; see Figure
Figure 5. Functionality of ICSBP-Transduced Cells 1). These results suggested that ICSBP repressed gran-
ulocytic differentiation in favor of stimulating macro-(A) Phagocytic activity. Cells from 6 days post transduction were
incubated with fluorescent latex particles for 2 hr. Left panels, phage differentiation. To further assess the role for
Wright-Giemsa stain; right panels, fluorescent micrograph of the ICSBP in granulocytic differentiation in other myeloid
same field (3 400). progenitor cells, we turned our attention to 32Dcl.3 (32D)
(B) Induction of IFNg/LPS-responsive genes . Cells at 6 days post cells.
transduction were pretreated with 200 U/ml IFNg for 2 hr followed 32D cells are nontransformed myeloid progenitor cells
by the addition of 200 ng/ml LPS for 6 hr. Indicated transcripts were
that grow in an IL-3-dependent manner. These cellsanalyzed by semiquantitative RT-PCR.
have the ability to differentiate into granulocytes in re-
sponse to G-CSF and have been extensively studied as
a model for myeloid cell differentiation (Valtieri et al.,which is shared by several other IRF family members
(Brass et al., 1999) (Figure 6A). The IAD is required for 1987). Immunoblot and RT-PCR analysis in Figure 7
showed that ICSBP was not expressed in 32D cells,the formation of ICSBP/IRF-1 and ICSBP/IRF-2 com-
plexes to bind tightly to the ISRE. The IAD is also re- serving a model to study the role for ICSBP in granulo-
cytic differentiation. 32D cells were transduced withquired for the formation of the ICSBP/PU.1 complex to
bind to the EICE. Both the DBD and IAD are required ICSBP virus or the control virus and their growth and
differentiation were monitored following treatment withfor transcriptional activity of ICSBP (Meraro et al., 1999).
To determine the domain of ICSBP required for macro- G-CSF (Figure 7). In the presence of IL-3, both ICSBP-
transduced cells and control cells grew at a rate similarphage differentiation, we constructed a DBD mutant in
which K at 79 was replaced with Glu (E) and additional to that of parental 32D cells (Figure 7A). When treated
with G-CSF in the absence of IL-3, control virus±C-terminal truncations shown in Figure 6A. EMSA exper-
iments (Figure 6C) performed with in vitro±translated transduced cells differentiated into granulocytes, as the
parental cells (Figure 7B). More than 40% of cellsmutants (Figure 6B) revealed that deletion of the a helix
motif in the C-terminal domain and the point mutation showed characteristic band/segmented nuclei. In con-
trast, typical granulocytic differentiation was not readilyin the DBD both completely abolished binding of the
ICSBP/IRF-2 complex to the ISRE and binding of the observed in ICSBP-transduced cells. Instead, these
cells showed an appearance of immature or intermedi-ICSBP/PU.1 complex to the EICE. Only the wild-type
ICSBP and the 1±390 truncation that retained the IAD ate cells, reminiscent of myelocytes or metamyelo-
tyctes, with only about 10% of cells having band/seg-bound to both the ISRE and EICE elements. Viruses
harboring the mutant ICSBPs were then constructed mented nuclei. We also noted that ICSBP-transduced
cells grew more slowly than control cells in the presenceand introduced into Tot2 cells and tested for their ability
to induce macrophage differentiation. Results in Figure of G-CSF (Figure 7A). Expression of G-CSFR, a G-CSF-
inducible granulocytic differentiation marker (Steinman6D demonstrated that all mutants that failed to bind to
the elements failed to induce macrophage differentia- and Tweardy, 1994), was examined by RT-PCR (Figure
7D). Although G-CSF treatment induced G-CSFR mRNAtion. In contrast, the 1±390 truncation, which retained
the binding activity for the elements, retained the ability in both types of cells, the transcript levels were much
lower in ICSBP-transduced cells than control cells.to induce macrophage differentiation. Cells transduced
with the 1±390 truncation differentiated into mature Oddly, ICSBP-transduced cells induced a macrophage
Regulation of Myeloid Differentiation by ICSBP
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Figure 6. ICSBP Domain Requirement for Macrophage Differentiation
(A) Diagram of the wild-type ICSBP and mutant ICSBPs. DNA binding domain (DBD), IRF association domain (IAD), and a putative a-helical
motif are indicated. The DNA binding activity and macrophage differentiation inducibility are summarized on the right.
(B) SDS-PAGE analysis of radiolabeled in vitro translation products tested in (C).
(C) EMSA analysis. In vitro translation products tested in (B) were analyzed with the ISRE (upper panel) or the EICE probe (lower panel).
(D) Wright-Giemsa stain of cells transduced with the wild-type ICSBP (WT) or indicated mutant ICSBP viruses for 4 days.
(E) RNA blot analysis. Total RNA (3 mg) from cells transduced with the indicated viruses for 4 days was analyzed with an ICSBP probe. The
lower panel indicates 28S ribosomal RNA.
(F) Semiquantitative RT-PCR analysis. RNA from cells transduced with the indicated viruses for 4 days were analyzed for indicated transcripts.
marker, SR gene after G-CSF treatment, which was un- longer divide and are turned over in 2 weeks (Unanue,
1993). When activated, macrophages elicit diverse func-detectable in control cells. These results indicate that
ICSBP perturbs G-CSF-mediated gene expression path- tions, such as enhanced phagocytosis, antimicrobial ac-
tivities, cytokine production, and antigen presentation,way in 32D cells, thereby inhibiting granulocytic differen-
tiation. all of which are fundamental to host defense against
infections.
Discussion
ICSBP as a Critical Regulator
of Macrophage DevelopmentIt has been long known that monocytes/macrophages
are derived from bipotential bone marrow progenitor We show that ICSBP directs myeloid progenitor cells to
differentiate into morphologically distinct, functionallycells and that, upon maturation, they migrate to the
peripheral tissues. Macrophages in the periphery no mature macrophages. Upon ICSBP virus transduction,
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Figure 7. Inhibition of Granulocytic Differen-
tiation in 32D Cells following ICSBP Trans-
duction, and a Model for the Role of ICSBP
in the Myeloid Cell Development
(A) The growth rates of 32D cells transduced
with control or ICSBP virus. Upper panel, cell
yields in the presence of IL-3; lower panel,
cell yields in the presence of G-CSF (10 ng/
ml) after IL-3 deprivation.
(B) Wright-Giemsa stain of virus-transduced
32D cells cultured in the presence of the indi-
cated growth factors.
(C) Immunoblot analysis of ICSBP expression
in virus-transduced 32D cells. Nuclear ex-
tracts (30 mg) were analyzed for ICSBP as in
Figure 2D.
(D) Gene expression after G-CSF treatment.
Virus-transduced 32D cells were cultured in
the presence of G-CSF for indicated days. On
day 0, cells were in the presence of IL-3 be-
fore G-CSF treatment. Indicated transcripts
were detected by semiquantitative RT-PCR.
(E) A model for ICSBP's role in lineage selec-
tion and macrophage differentiation. ICSBP
may play a role in the lineage selection of
myeloid progenitor cells by stimulating ex-
pression of a series of genes along the mac-
rophage differentiation pathway. This pro-
cess may be coupled with the repression of
genes specifying granulocytic differentiation.
the Tot2 progenitor cells induced macrophage-specific the immunoglobulin light chain genes (Eisenbeis et al.,
1995), EICE-like elements appear to be present in somemarkers, c-fms, F4/80, and enhanced Mac-1 (CD11b)
expression. These cells exhibited strong phagocytic ac- promoters active in myeloid cells (Eklund and Kakar,
1999; Rehli et al., 2000), including the SR (Fujii et al.,tivity, a hallmark of macrophage function. Moreover,
ICSBP-transduced cells acquired the capacity to re- 1999), induced upon ICSBP transduction (Figure 4).
However, immediate target genes activated and/or re-spond to IFNg/LPS and induced IL-12 p40, iNos, and
FcgRI transcripts. These and the observations that pressed by ICSBP that can trigger macrophage differen-
tiation in the progenitor cells have not been identified.ICSBP-stimulated SR expression and repressed MPO
indicate that ICSBP transduction leads to the differentia- Complicating the identification of target genes, recent
studies indicate that ICSBP acts on a wide range oftion of bona fide macrophages. Another feature that
supports the role for ICSBP in stimulating authentic target elements beyond the ISRE and EICE (Contursi et
al., 2000; Wang et al., 2000). It is possible that the targetmacrophage differentiation is the complete cell growth
arrest seen after virus transduction. Together, our re- genes regulated by ICSBP during macrophage differen-
tiation may include those unrelated to the ISRE andsults indicate that ICSBP activates developmentally pre-
determined pattern of gene expression in a sequentially EICE.
It is interesting to note that ICSBP induced a zincordered fashion and leads to complete macrophage dif-
ferentiation. finger transcription factor Egr-1 in Tot2 cells, which has
been implicated for macrophage differentiation (Nguyen
et al., 1993) (Figure 4B). This factor, when ectopicallyTranscriptional Pathways Regulated by ICSBP
expressed, induces a limited degree of macrophage dif-We have shown that ICSBP transduction leads to activa-
ferentiation in several cultured cell lines, although stud-tion of ISRE and EICE DNA binding activities in Tot2
ies of Egr-12/2 mice indicate the presence of redundantcells. By testing various mutant constructs, we also
mechanisms capable of compensating the Egr-1 activityshowed that ICSBP's ability to induce macrophage dif-
(Lee et al., 1996). Our results indicate that ICSBP actsferentiation precisely correlated with its ability to bind
upstream of Egr-1 and may suggest that, once Egr-1 isto these elements. It is reasonable to envisage that mac-
induced by ICSBP, it may generate a secondary cascaderophage differentiation induced by ICSBP is dependent
of gene expression emanating from Egr-1.on transcription of genes carrying these elements. The
ISREs are found in a number of IFN-inducible genes as
well as other genes regulated by proteins of the IRF A Role for ICSBP in Lineage Selection
Another striking pattern of gene expression observedfamily. ICSBP generally acts as a repressor in some
ISRE-carrying promoter. On the other hand, ICSBP, by after ICSBP transduction is the repression of genes
known to promote granulocytic differentiation. C/EBPaassociating with PU.1 activates transcription from pro-
moters carrying the EICE (Eklund and Kakar, 1999; Mar- and C/EBPe, transcription factors of the bZip family are
shown to be involved in the development and maturationecki et al., 1999). While the EICE was first identified in
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into pBluescript SKII(1) (Stratagene) and pMSCVpuro (Clontech).of granuloctyes (Yamanaka et al., 1997; Radomska et al.,
The nucleotide sequence of all constructs was confirmed by se-1998). These and G-CSFR were clearly downregulated
quencing.in ICSBP-transduced cells. The reduced G-CSFR may
result in the attenuation of G-CSF-mediated signaling.
Retroviral TransductionFurthermore, we found that ectopic expression of ICSBP
BOSC23 ecotropic retroviral packaging cells (Pear et al., 1993) wereinhibits granulocytic differentiation in Tot2 as well as
transiently transfected with pMSCV retroviral vectors using Lipofec-32Dcl.3 cells. Both cells were, otherwise, endowed with
tamine 2000 (GIBCO-BRL) according to the manufacturer's protocol.
the ability to differentiate into granulocytes when stimu- Retroviral supernatants were collected at 48 hr. Cells were trans-
lated by G-CSF. duced by spinoculation (3000 rpm, 338C, 1 hr) in a retroviral superna-
These results suggest that, while ICSBP stimulates tant supplemented with cytokines and 4 mg/ml polybrene. Trans-
expression of genes critical for macrophage differentia- duced cells were selected with 2 mg/ml puromycin 48 hr after
spinoculation. The transduction efficiency was 10%±20% for Tot2tion, it represses a series of genes required for granulo-
cells and higher than 80% for 32D cells. Virus titers measured usingcytic differentiation and that the two events are internally
NIH3T3 were .1 3 106 infectious particles/ml.coupled through the action of ICSBP. The dual mode
of ICSBP action suggests that it plays a critical role in
Flow Cytometric Analysisthe lineage selection of myeloid progenitor cells (Figure
Cells were blocked with anti-mouse FcgR antibody (CD16/CD32,7E). The lineage selection capacity of ICSBP suggested
2.4G2) and stained with fluorescein isothiocyanate (FITC)±con-in this work is compatible with several phenotypic fea-
jugated antibodies against Mac-1 (CD11b), F4/80, Thy-1.2 (CD90.2),tures of ICSBP2/2 mice; ICSBP2/2 mice show an abnor-
or phycoerytherin (PE)±conjugated antibodies against Gr-1 (Ly-6G),
mal expansion of granulocytes from an early stage of or B220 (CD45R). All antibodies were purchased from Pharmingen,
development (Holtschke et al., 1996). The macrophage except F4/80 from Caltag. Stained cells were analyzed on FACSCali-
colony±forming ability is impaired in ICSBP2/2 bone mar- bur using the CellQuest software (Becton Dickinson). Live cells were
row cells, which contain fewer monocyte/macrophage electronically gated using forward and side scatter parameters. For
cell cycle analysis, cells were fixed in cold 70% ethanol, treatedlineage cells (Scheller et al., 1999). In addition, Mac-11
with RNase A, and stained with propidium iodide. Stained cells wereand Gr-12 monocytes/macrophages in ICSBP2/2 mice
analyzed on FACSCalibur using CellQuest, and cell cycle profilesshow functional defects in several criteria (Fehr et al.,
were obtained by the ModFitLD V2.0 software (Becton Dickinson).1997; Scharton et al., 1997; Wu et al., 1999). In view of
the involvement of ICSBP in regulating cell growth in
Semiquantitative RT-PCRTot2 and 32D cells (Figures 3 and 7), it is not surprising
Semiquanititative RT-PCR was performed as described previouslythat ICSBP is implicated for myeloid cell malignancies,
(Kuwata et al., 2000). The following primers were used: ICSBPparticularly CML (Schmidt et al., 1998; Hao and Ren, (sense, 59-ATGTGTGACCGGAACGGCGG-39; antisense, 59-CAGAA
2000). GGTTCCTTGATCAGC-39); Egr-1 (sense, 59-CAACTACCCCAAACT
In conclusion, ICSBP provides critical guidance to GGAGGAG-39; antisense, 59-GAGGATTGGTCATGCTCACGAG-39).
myeloid cell development by playing a role in progenitor Primers for c-fms, SR, GM-CSFRa, GM-CSFRbc, MPO, G-CSFR,
lineage selection and stimulating macrophage differenti- b-actin (DeKoter et al., 1998), PU.1 (Anderson et al., 1999), C/EBPa
(Hansen et al., 1999), C/EBPe (Yamanaka et al., 1997), iNos, FcgRIation.
(Contursi et al., 2000), and IL-12 p40 (Scharton et al., 1997) were as
described.
Experimental Procedures
Phagocytosis AssayCells and Cell Culture
Cells were cultured in the presence of 0.026% of fluorescent latexTot2 cells were maintained in RPMI1640 (Quality Biological) supple-
beads (Fluoresbrite Carboxylate 0.75 Micron Microspheres, Poly-mented with 2 mM L-Glutamine, 100 U/ml penicillin, and 100 mg/ml
sciences) for 2 hr and washed three times in PBS. Cells were cyto-streptomycin (complete RPMI) with 20% fetal bovine serum (FBS,
centrifuged onto a glass slide, stained with the Wright-Giemsa solu-Atlantic Biologicals) and 6 ng/ml recombinant murine GM-CSF (Bio-
tion, and viewed on a Zeiss Axiophot microscope.source International). BOSC23 (ATCC) were cultured in Dulbecco's
modified Eagle's medium (Quality Biological) containing 2 mM
L-glutamine, 10% FBS, and penicillin/streptomycin. 32Dcl.3 (32D) RNA Blot and Immunoblot Analyses
cells were a kind gift from Dr. S. Soddu and grown in complete Total RNA (3 mg) electrophoresed on a 1% agarose formaldehyde
RPMI with 10% FBS and 10% conditioned medium from WEHI-3B gel was transferred onto a nylon membrane and hybridized with
cells as a source of IL-3. Tot2 cells were established from bone 32P-labeled ICSBP 1±253 probe prepared by random priming using
marrow cells from ICSBP2/2 mice undergoing blast crisis. Nonadher- ReadyToGo (Pharmacia Biotech). Nuclear extracts were prepared
ent cells growing on stromal cell layer were transferred to the me- as described (Andrews and Faller, 1991). Immunoblot analysis was
dium containing 6 ng/ml recombinant GM-CSF. The Tot2 cell line performed using 30 mg of nuclear extracts and rabbit antibody
was cloned by limiting dilution. Recombinant G-CSF (Peprotech) against the C-terminal amino acids of ICSBP as previously de-
and M-CSF (R & D systems) were added at 10 ng/ml. Morphologic scribed (Politis et al., 1994).
differentiation was monitored by Wright-Giemsa staining of cytospin
preparations. At least 250 cells were counted by two investigators. EMSA
IFNg (generously provided by Genentech) was used at 200 U/ml Nuclear extracts were prepared from 3-day-old Tot2 cells trans-
and LPS from Escherichia coli (Sigma) at 200 ng/ml. duced with ICSBP or control virus as described (Andrews and Faller,
1991). In vitro translation (IVT) products were prepared using TNT
T7 Quick Coupled Transcription/Translation System (Promega) ac-DNA Constructs
The truncation mutant 1±253 was generated by removing the cording to manufacturer's protocol. ICSBP cDNA and its mutant
constructs in pBluescript SKII(1), murine IRF-2 cDNA in pSVK3 (aC-terminal region of ICSBP cDNA by EagI followed by insertion of
a linker containing stop codon. Other mutants were obtained by gift from Dr. J. Hiscott), or murine PU.1 cDNA in pSG5 (a gift from
Dr. H. Singh) were used as templates. EMSA was performed asPCR using Pfu polymerase (Stratagene). The point mutant K79E
was generated by PCR using sense primer containing this mutation, previously described (Kanno et al., 1993). Nuclear extracts (10 mg
for ISRE and 3 mg for EICE) or 0.5 ml of IVT proteins were subjected59-AACCAGCCACGTGGGAGACGAGGTTACGCTGTGC-39, and anti-
sense primer 59-CAGAAGGTTCCTTGATCAGC-39. The PCR product to protein±DNA binding reaction in a total volume of 15 ml and
resolved on a 4.5% PAGE. The DNA probes, murine ISG15 ISREwas digested with BclI and PmlI and replaced to the BclI/PmlI por-
tion of ICSBP cDNA. Wild-type and mutant ICSBPs were ligated (Kanno et al., 1993) and the murine lB EICE (Ortiz et al., 1999)
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were end labeled with [32P]ATP using T4 polynucleotide kinase (New Hawley, R.G., Lieu, F.H., Fong, A.Z., and Hawley, T.S. (1994). Versa-
tile retroviral vectors for potential use in gene therapy. Gene Ther.England Biolabs).
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